Immediate Impact
1 by Nobel laureates 37 from Science/Nature 61 standout
Citing Papers
Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease
2021 Standout
Therapeutic options in VEXAS syndrome: insights from a retrospective series
2021 Standout
Works of Nikolas von Bubnoff being referenced
Ruxolitinib for Glucocorticoid-Refractory Acute Graft-versus-Host Disease
2020 Standout
Ruxolitinib in GvHD (RIG) study: a multicenter, randomized phase 2 trial to determine the response rate of Ruxolitinib and best available treatment (BAT) versus BAT in steroid-refractory acute graft-versus-host disease (aGvHD) (NCT02396628)
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Nikolas von Bubnoff | 1933 | 1309 | 1077 | 1102 | 134 | 4.0k | |
| Ali G. Turhan | 1990 | 1363 | 1020 | 1497 | 181 | 3.9k | |
| Marc Loriaux | 2158 | 2060 | 796 | 1956 | 96 | 4.5k | |
| Philippe Martiat | 1520 | 1416 | 1301 | 2007 | 109 | 5.5k | |
| Ronald Paquette | 3179 | 2321 | 596 | 1509 | 117 | 4.9k | |
| Michael H. Tomasson | 1786 | 652 | 1230 | 1608 | 115 | 3.5k | |
| Philipp Erben | 1964 | 1741 | 625 | 804 | 159 | 3.7k | |
| Steffen Koschmieder | 2344 | 1651 | 714 | 2719 | 219 | 5.1k | |
| Ramón V. Tiu | 3450 | 1980 | 544 | 2208 | 159 | 5.0k | |
| Juan Luis Garcı́a | 1202 | 820 | 970 | 1254 | 127 | 3.2k | |
| Preetesh Jain | 1376 | 2050 | 973 | 618 | 179 | 3.4k |
All Works
Login with ORCID to disown or claim papers
Loading papers...